G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,983 | -94.8% | 21,516 | -91.0% | 0.00% | – |
| Q2 2023 | $596,626 | +8.9% | 239,609 | +17.2% | 0.00% | – |
| Q1 2023 | $547,696 | -44.9% | 204,364 | +11.6% | 0.00% | – |
| Q4 2022 | $994,331 | -56.0% | 183,118 | +1.2% | 0.00% | -100.0% |
| Q3 2022 | $2,260,000 | +194.3% | 180,891 | +16.5% | 0.00% | – |
| Q2 2022 | $768,000 | -62.1% | 155,315 | -41.7% | 0.00% | -100.0% |
| Q1 2022 | $2,025,000 | -23.9% | 266,345 | +2.2% | 0.00% | 0.0% |
| Q4 2021 | $2,662,000 | -17.4% | 260,701 | +8.6% | 0.00% | 0.0% |
| Q3 2021 | $3,223,000 | -38.7% | 240,133 | +0.1% | 0.00% | -50.0% |
| Q2 2021 | $5,262,000 | -3.6% | 239,804 | +5.8% | 0.00% | 0.0% |
| Q1 2021 | $5,456,000 | +50.5% | 226,750 | +12.5% | 0.00% | +100.0% |
| Q4 2020 | $3,626,000 | +56.2% | 201,518 | +0.3% | 0.00% | 0.0% |
| Q3 2020 | $2,322,000 | -52.0% | 200,999 | +0.7% | 0.00% | -50.0% |
| Q2 2020 | $4,841,000 | +135.6% | 199,539 | +7.0% | 0.00% | +100.0% |
| Q1 2020 | $2,055,000 | -57.5% | 186,458 | +2.0% | 0.00% | -66.7% |
| Q4 2019 | $4,834,000 | +18.0% | 182,880 | +1.7% | 0.00% | +50.0% |
| Q3 2019 | $4,095,000 | -19.8% | 179,739 | +8.0% | 0.00% | -33.3% |
| Q2 2019 | $5,103,000 | +119.0% | 166,430 | +18.6% | 0.00% | +200.0% |
| Q1 2019 | $2,330,000 | -9.9% | 140,351 | +4.0% | 0.00% | -50.0% |
| Q4 2018 | $2,585,000 | -59.8% | 134,960 | +9.8% | 0.00% | -50.0% |
| Q3 2018 | $6,428,000 | +243.9% | 122,918 | +185.9% | 0.00% | +300.0% |
| Q2 2018 | $1,869,000 | +74.5% | 43,000 | +48.8% | 0.00% | 0.0% |
| Q1 2018 | $1,071,000 | +269.3% | 28,900 | +97.9% | 0.00% | – |
| Q4 2017 | $290,000 | -20.3% | 14,600 | 0.0% | 0.00% | – |
| Q3 2017 | $364,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |